Clinicodemographic Profile of Kidney Diseases in a Tertiary Hospital of Central Nepal, Chitwan: A Descriptive Cross-sectional Study
Introduction: Spectrum of kidney diseases differs significantly in developing and developed
countries. However, there is no central registry regarding the nature of such diseases in Nepal
and our center either. The study aims to know the clinicodemographic spectrum of kidney disease
patients admitted to our hospital.
Methods: This study was a descriptive cross sectional study done in the department of Nephrology,
College of Medical Sciences Teaching Hospital from May 2018 to April 219. Convenient sampling
was done and all the consecutive kidney disease patients irrespective of their age, sex, and renal
diagnosis were included in the study. Ethical approval was taken from the Institutional Review
Committee of the college (reference number. 2016/COMSTH/IRC/049). Clinicodemographic profile
of kidney diseases were studied using statistical package for the social sciences version 20 and were
represented as mean, standard deviation, number, percentage and ratio.
Results: Out of a total of 829 patients, the commonest clinical syndrome and the histological patterns
were end-stage renal disease 248 (29.9%) and IgA nephropathy 18 (20.7%) respectively. The mean
age was 51.4±18.6 years. The commonest reason for hospitalization was sepsis 372 (44.8%). Males
were 486 (58.6%) and females were 343 (41.4%).
Conclusions: The commonest clinical presentation and the reason for admissions were end-stage
renal disease and sepsis syndrome respectively.
Copyright (c) 2020 Madhav Ghimire, Shreeju Vaidya, Hari Prasad Upadhyay
This work is licensed under a Creative Commons Attribution 4.0 International License.
JNMA allow to read, download, copy, distribute, print, search, or link to the full texts of its articles and allow readers to use them for any other lawful purpose. The author(s) are allowed to retain publishing rights without restrictions. The JNMA work is licensed under a Creative Commons Attribution 4.0 International License. More about Copyright Policy.